You are here

Article Text

Article menu
Download PDFPDF
Basic Science
140 Acetylated ldl induces IL-1β release from human coronary endothelial cells
  1. Majid Almansouri1,
  2. Sheila Francis2,
  3. Janet Chamberlain2
  1. 1The University of Sheffield, Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Beech Hill Road, Sheffield, UK
  2. 2Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield

Abstract

Background Atherosclerosis is a chronic vascular inflammatory disease characterised by disturbed arterial blood flow due to the atheromatous plaque build-up within arterial layers. Lipid rich plaques contain various forms of cholesterol, such as acetylated low density lipoprotein (AcLDL), that undergo many modification processes and which enter vascular cells, initiating over exuberant repair processes leading to arterial occlusion and life threatening myocardial infarction or stroke. Endothelial cells (EC) strongly drive the pathogenesis of atherosclerosis by producing pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β). We have recently shown that the release of IL-1β from EC occurs via extracellular lysosomal derived vesicles, but the stimuli and mechanisms by which IL-1β is released remain to be fully elucidated. We hypothesise that AcLDL enters the arterial endothelium and induces IL-1 secretion, potentially via a caspase-1/NLRP3 mechanism.

Methods Human coronary artery endothelial cells (HCAEC) isolated from three different donors were cultured and stimulated with pro-inflammatory cytokines TNF-α and IL-1β (10 ng/ml each, for 48 hours), followed by incubation with native human AcLDL cholesterol at multiple concentrations (10–200 ug/ml) for 6 hours. Cell lysates and culture supernatants were collected and analysed for IL-1β using ELISA. Cell viability was also measured.

Results AcLDL induced the release of IL-1β from stimulated HCAECs in a dose dependent manner with maximum release (155.4 pg/ml, n=3) at concentration of 50 ug/ml. This was 4 fold greater than that released by cytokine-stimulated (38.49 pg/ml, n=3) and 3 fold greater than that released by neutrophil elastase (49.45 pg/ml, n=3). This release was not caused by toxicity of the AcLDL: cell viability was confirmed by lactate dehydrogenase cell viability assay.

Figure

Abstract 137 Figure 1

Figure

Abstract 137 Figure 2

Figure

Abstract 137 Figure 3

View this table:

Abstract 137 Table 1

View this table:

Abstract 137 Table 2

View this table:

Abstract 137 Table 3

View this table:

Abstract 137 Table 4

Conclusion AcLDL is capable of eliciting IL-1β release in activated HCAECs, without causing toxicity.

  • Athersclerosis
  • AcLDL
  • IL-1±

https://doi.org/10.1136/heartjnl-2018-BCS.137

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.